Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial
Kristian Reich, Jacob P. Thyssen, Andrew Blauvelt, et al.
The Lancet (2022) Vol. 400, Iss. 10348, pp. 273-282
Closed Access | Times Cited: 154

Showing 1-25 of 154 citing articles:

JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens
Qian Hu, Qihui Bian, Dingchao Rong, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 142
JAK–STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review
I‐Hsin Huang, Yi‐Teng Hung, Po‐Chien Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 140
Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies
Dawn Marie R. Davis, Aaron M. Drucker, Ali Alikhan, et al.
Journal of the American Academy of Dermatology (2023) Vol. 90, Iss. 2, pp. e43-e56
Closed Access | Times Cited: 73
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
Pavel Kolkhir, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 743-767
Closed Access | Times Cited: 68
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
Dongze Wu, Yingzhao Jin, Yuhan Xing, et al.
EClinicalMedicine (2023) Vol. 64, pp. 102193-102193
Open Access | Times Cited: 68
Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials
Alexandro Chu, Melanie Wong, Daniel Rayner, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 6, pp. 1470-1492
Open Access | Times Cited: 60
Treatment of atopic dermatitis: Recently approved drugs and advanced clinical development programs
Svenja Müller, Laura Maintz, Thomas Bieber
Allergy (2024) Vol. 79, Iss. 6, pp. 1501-1515
Open Access | Times Cited: 49
Sensory neurons promote immune homeostasis in the lung
Masato Tamari, Kate L. Del Bel, Aaron Ver Heul, et al.
Cell (2023) Vol. 187, Iss. 1, pp. 44-61.e17
Open Access | Times Cited: 48
JAK-STAT pathway inhibitors in dermatology
Hélio Amante Miot, Paulo Ricardo Criado, Caio César Silva de Castro, et al.
Anais Brasileiros de Dermatologia (2023) Vol. 98, Iss. 5, pp. 656-677
Open Access | Times Cited: 47
Optimal Use of Jak Inhibitors and Biologics for Atopic Dermatitis on the Basis of the Current Evidence
Masahiro Kamata, Yayoi Tada
JID Innovations (2023) Vol. 3, Iss. 3, pp. 100195-100195
Open Access | Times Cited: 44
Interleukin-4 as a therapeutic target
Yvonne Gärtner, Lynn Bitar, Frauke Zipp, et al.
Pharmacology & Therapeutics (2023) Vol. 242, pp. 108348-108348
Closed Access | Times Cited: 43
Current perspectives and trend of computer-aided drug design: a review and bibliometric analysis
Zhenhui Wu, Shupeng Chen, Yihao Wang, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 24
Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors
Richard W. Kim, Megan Lam, Katrina Abuabara, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 2, pp. 179-193
Closed Access | Times Cited: 20
JAK inhibitor selectivity: new opportunities, better drugs?
Anniina Virtanen, Francesca Romana Spinelli, Jean Baptiste Telliez, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 10, pp. 649-665
Closed Access | Times Cited: 18
Recent Advancements in the Atopic Dermatitis Mechanism
Maria Savva, Nikolaos G. Papadopoulos, Stamatios Gregoriou, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 2
Open Access | Times Cited: 17
Real‐World Efficacy and Safety of Abrocitinib in Chinese Atopic Dermatitis Patients: A Single‐Center Prospective Study
Zheng Li, Yu Wang, Yuemeng Wu, et al.
Allergy (2025)
Closed Access | Times Cited: 4
Atopic dermatitis
Emma Guttman‐Yassky, Yael Renert‐Yuval, Patrick M. Brunner
The Lancet (2025) Vol. 405, Iss. 10478, pp. 583-596
Closed Access | Times Cited: 3
Oral Janus kinase inhibitors for atopic dermatitis
Daniela Mikhaylov, Benjamin Ungar, Yael Renert‐Yuval, et al.
Annals of Allergy Asthma & Immunology (2023) Vol. 130, Iss. 5, pp. 577-592
Open Access | Times Cited: 37
Cardiovascular and Venous Thromboembolic Risk With JAK Inhibitors in Immune-Mediated Inflammatory Skin Diseases
Jenne P. Ingrassia, Muhammad Haisum Maqsood, Joel M. Gelfand, et al.
JAMA Dermatology (2023) Vol. 160, Iss. 1, pp. 28-28
Closed Access | Times Cited: 31
Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis
Helena Iznardo, Esther Roé, E. Serra‐Baldrich, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 385-385
Open Access | Times Cited: 23
Systemic Immunomodulatory Treatments for Atopic Dermatitis
Aaron M. Drucker, Megan Lam, David Prieto‐Merino, et al.
JAMA Dermatology (2024) Vol. 160, Iss. 9, pp. 936-936
Closed Access | Times Cited: 15
Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry
Esmé Kamphuis, Celeste M. Boesjes, Laura Loman, et al.
Acta Dermato Venereologica (2024) Vol. 104, pp. adv19454-adv19454
Open Access | Times Cited: 13
Integrated Safety Update of Abrocitinib in 3802 Patients with Moderate-to-Severe Atopic Dermatitis: Data from More than 5200 Patient-Years with Up to 4 Years of Exposure
Eric L. Simpson, Jonathan I. Silverberg, Audrey Nosbaum, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 4, pp. 639-654
Open Access | Times Cited: 9
Infections in Patients with Atopic Dermatitis and the Influence of Treatment
Maddalena Napolitano, Maria Esposito, Maria Concetta Fargnoli, et al.
American Journal of Clinical Dermatology (2025)
Open Access | Times Cited: 1
Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases—a systematic literature review informing the 2024 update of an international expert consensus statement
Victoria Konzett, Josef S Smolen, Peter Nash, et al.
Annals of the Rheumatic Diseases (2025)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top